What move does the options market price into PDS Biotechnology's report?

Implied ±19.9%, either direction.

PDSBNasdaqPharmaceutical Preparations

PDS Biotechnology Corp (PDSB) earnings date, market-implied expected move, and options open interest by expiry

1.23

+0.06 · +5.13%

post 1.23 −0.05%

After hours16:12 ETdelayed

Open1.07Volume3.6MMkt cap$65.5MEPS-0.63

Day1.07 – 1.2684%52-wk0.20 – 1.7965%

PDSB

PDS Biotechnology Corp

OpenVolumeMkt capP/EEPSDiv yield

Day – 52-wk –

Expected move

Inputs

±19.9%implied · report alone

0.981.47

straddle ±26.0%

spot 1.22exp Nov 13ATM strike 1ATM straddle 0.37IV 256%

Nov 6 closereport share · term structure

Expected move

Inputs

Next report

Nov 12

before open · in 6 days

est.Q3 FY26

Calendar

Next report

Last report

−3.64%

shaded = implied · ▲▼ = realized

Aug 13 '26 · confirmed

Implied vs realized

Linked news

2dMRK · customerMerck posts nine-month net loss of $510 million; Q3 net income $5,065 million

News

Largest filed tie

13F top-10 QoQ

+18.71%

shares held · 10 largest managers

13F · Jun 30 '26129d lag

50 managers

Top fund weight

0.00%

PDSB weight · VTI

N-PORTJun 30 '26

1 fund

Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied

PDS Biotechnology (PDSB) is expected to report on Nov 12 before open (estimated date).

Implied vs realized

1 report

—≥ implied

Q2 FY26Aug 13 '26confirmed—▼−3.64%—

quarterimplied−5%0+5%realized×

Q2 FY26—▼−3.64%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Implied vs realized

Positioning

OI · 6 expiries · Nov 3 close

14.58OI · 6 expiries · Nov 3 closeP/C open interest · Nov 13 · first expiry after the report

PUTS · chgexpiry · days · P/CCALLS · chgP/C

520−59%Nov 60d0.281,866+37%0.28

report · Nov 12 · before open · est.

1,458—Nov 137d100—

3,150−21%Nov 2014d0.2910,851−5%0.29

118+9%Nov 2721d0.41286+34%0.41

2 later expiries

123—Dec 1842d0.16788—0.16

848−18%Feb 19105d0.155,783+4%0.15

ExpiryPutsCallsP/C

Nov 60d520−59%1,866+37%0.28

report · Nov 12 · before open · est.

Nov 137d1,458—100—14.58

Nov 2014d3,150−21%10,851−5%0.29

Nov 2721d118+9%286+34%0.41

2 later expiries

Dec 1842d123—788—0.16

Feb 19105d848−18%5,783+4%0.15

Hatched = puts · solid = calls · bars scaled per expiry · chg = OI vs prior sessionSource: options EOD

Positioning

Linked exposure

scenario · straddle±26.0%

Funds 1

VTI±0.0%

Dashed = straddleMethod Source: SEC filings · N-PORT · market data

Linked exposure

Revenue flow

No filed income statement.

Revenue flow

Intraday

15m bars

Long dash = implied range · Nov 6 close · Hatch = extended hours · ▯ up · ▮ downSource: market data · 16:00 ET

Intraday

Event sensitivity

FOMC ×1.49· ±6.7% vs ±4.5% · 24 releases

eventrelease day|move|up · n×base

FOMCrate decision±6.7%11 of 24×1.49

PPIproducer prices±5.8%4 of 10×1.29

NFPjobs report±5.0%5 of 10×1.12

GDPgross domestic product±3.9%10 of 19×0.87

CPIconsumer prices±3.9%5 of 10×0.87

CPROFcorporate profits±3.0%7 of 12×0.67

PCEpersonal income & outlays±2.5%8 of 19×0.57

Bar = avg |move| to ±7% · tick = ±4.5% avg day · ×base = |move| ÷ ±4.5% · min 6 releases

Earnings history

EPS -0.18 · consensus —

Quarter	Reported	EPS	Consensus
Q2 FY26	Aug 13 '26 · confirmed	-0.18	—
Q1 FY26	—	-0.13	—
Q3 FY25	—	-0.19	—

Source: filed financials

Methodology

ties · implied moves · holdersMethod